Table 3.
City | RD | Asthma | URI | COPD | ||||
---|---|---|---|---|---|---|---|---|
RR (95% CI) | P-value | RR (95% CI) | P-value | RR (95% CI) | P-value | RR (95% CI) | P-value | |
Atlanta | 1.03 (1.01-1.05) | <0.01 | 1.04 (1.02-1.07) | <0.01 | 1.03 (1.01-1.05) | <0.01 | 1.00 (0.96-1.04) | 0.963 |
Birmingham | 1.03 (1.00-1.06) | 0.023 | 1.04 (0.98-1.11) | 0.151 | 1.03 (0.99-1.06) | 0.114 | 0.99 (0.92-1.07) | 0.844 |
Dallas | 1.05 (1.02-1.07) | <0.01 | 1.04 (1.00-1.08) | 0.047 | 1.06 (1.03-1.09) | <0.01 | 1.05 (0.99-1.11) | 0.110 |
Pittsburgh | 1.03 (1.01-1.05) | <0.01 | 1.04 (1.01-1.08) | 0.023 | 1.03 (1.00-1.06) | 0.072 | 1.03 (0.98-1.09) | 0.246 |
St. Louis | 1.02 (1.01-1.04) | 0.011 | 1.07 (1.03-1.11) | <0.01 | 1.01 (0.99-1.04) | 0.269 | 1.04 (0.98-1.10) | 0.177 |
P-value testing whether city RRs differ3 | 0.748 | 0.765 | 0.184 | 0.564 |
P-values from chi-square tests of city heterogeneity